Lipohypertrophy isn’t life-threatening on its own, but it creates real danger by disrupting how your body absorbs insulin. These lumpy, thickened areas of fat tissue that form at overused injection sites can make insulin up to 30% less effective, leading to blood sugar swings that are both unpredictable and difficult to manage. For anyone who relies on insulin, that level of disruption is a serious problem.
How Lipohypertrophy Disrupts Insulin Absorption
The core danger of lipohypertrophy comes down to what happens when you inject insulin into affected tissue. The thickened, rubbery fat doesn’t absorb insulin the way healthy tissue does. In studies measuring how insulin moves from the injection site into the bloodstream, injecting into lipohypertrophy tissue produced 46% less total insulin absorption over five hours compared to injecting into normal skin. Peak insulin levels in the blood were 25% lower.
The practical result: blood sugar stayed nearly 40% higher for over five hours after a meal, and maximum blood sugar spiked 25% higher than it would have with a normal injection site. That kind of sustained elevation is exactly the pattern that drives long-term complications in diabetes, from nerve damage to kidney problems to cardiovascular disease.
A large meta-analysis found that people with lipohypertrophy had HbA1c levels (a measure of average blood sugar over roughly three months) that were 0.55 percentage points higher than people without it. They also used about 7.7 more units of insulin per day. That’s a meaningful increase in both cost and complication risk, especially over years of treatment.
The Hidden Risk: Unpredictable Low Blood Sugar
High blood sugar is only half the problem. Lipohypertrophy tissue doesn’t just absorb insulin poorly. It absorbs it erratically. Insulin can pool in the damaged tissue and release unpredictably, sometimes causing a delayed blood sugar crash hours after an injection. In one study of young people with type 1 diabetes, 23% reported unexplained hypoglycemic events linked to injection site problems.
This is where lipohypertrophy becomes genuinely dangerous in the short term. Severe low blood sugar can cause confusion, loss of consciousness, seizures, and in rare cases, death. When these episodes seem to come out of nowhere, they’re especially hard to prevent because neither you nor your care team can identify a clear dosing error. The culprit is the tissue itself, releasing stored insulin on its own unpredictable schedule.
How Common It Is
Lipohypertrophy is far more common than most people realize. A systematic review using ultrasound detection found it in roughly 71% of people with type 1 diabetes and 58% of people with type 2 diabetes who use insulin injections. Many cases go undiagnosed because the lumps develop gradually and can be difficult to spot without careful examination.
The high prevalence means this isn’t a rare complication. If you inject insulin regularly, there’s a better-than-even chance you have some degree of lipohypertrophy, whether or not you’ve noticed it.
How to Check for It
Lipohypertrophy feels like a thickened, rubbery patch of skin at or near your injection sites. Some lumps are flat and blend into surrounding tissue, while others protrude noticeably. They range from small (under 4 cm across) to large plates of thickened tissue, particularly on the abdomen, which is the most common injection area.
You can check by using a simple pinch test. Gently pinch the skin at your most-used injection site between two fingers, then compare it to a nearby area where you never inject. If the fold at the injection site feels significantly thicker or firmer, that’s a strong indicator. Looking at the area under side lighting against a dark background can also reveal subtle swelling that’s invisible under normal overhead light. Protruding lumps larger than 4 cm are more common on the abdomen, where repeated injections tend to concentrate.
What Causes It
Two habits drive lipohypertrophy: injecting in the same spot repeatedly and reusing needles. Insulin itself has growth-promoting properties, so delivering it to the same small area over and over stimulates local fat tissue to enlarge. Reused needles compound the problem because they develop microscopic barbs after even a single use, causing more tissue trauma with each injection.
Many people develop a preferred injection site because lipohypertrophy tissue is actually less sensitive to pain. The damaged nerves in the area make injections feel easier, which creates a cycle: the lump makes the spot less painful, so you keep using it, and the lump grows larger.
Can It Be Reversed?
Lipohypertrophy does not resolve quickly, and in some cases it may not fully reverse at all. Research on children with type 1 diabetes showed that even after completely avoiding affected injection sites for six months, ultrasound still detected tissue changes. Larger, more established lumps are particularly stubborn.
That said, avoiding the affected area is still the most important step. Even if the tissue doesn’t return to completely normal, switching to unaffected injection sites immediately improves insulin absorption. The critical thing to know is that when you move to a new site, you may need less insulin than before, because healthy tissue absorbs it so much more efficiently. Working with your care team to adjust your dose when switching sites helps prevent dangerous lows during the transition.
How to Prevent It
Consistent site rotation is the single most effective prevention strategy. This means not just alternating between your left and right sides, but systematically moving your injection point within each area so that no single spot receives repeated injections within a short window. Some people find it helpful to mentally divide their injection area into a grid and move through it methodically.
Using a fresh needle for every injection also reduces risk. Each reuse increases tissue trauma and makes the area more prone to developing thickened fat deposits. The combination of proper rotation and single-use needles substantially lowers the chance of lipohypertrophy forming in the first place, keeping your insulin working as predictably as possible.